6 15

Cited 0 times in

Cited 0 times in

Tau PET imaging as a mediator between glymphatic dysfunction and cognitive decline: a cross-sectional and longitudinal study

DC Field Value Language
dc.contributor.authorKo, Juyeon-
dc.contributor.authorSon, Gayeong-
dc.contributor.authorSeo, Ha Eun-
dc.contributor.authorCho, Jaelim-
dc.contributor.authorKim, Jae-Yoon-
dc.contributor.authorLee, Sang-Yoon-
dc.contributor.authorKim, Daegyeom-
dc.contributor.authorPark, Shineui-
dc.contributor.authorPark, Kee Hyung-
dc.contributor.authorLockhart, Samuel N.-
dc.contributor.authorKim, Dong-Hyun-
dc.contributor.authorNoh, Young-
dc.date.accessioned2026-03-11T00:17:27Z-
dc.date.available2026-03-11T00:17:27Z-
dc.date.created2026-03-09-
dc.date.issued2026-01-
dc.identifier.issn1619-7070-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/211094-
dc.description.abstractPurposeImpaired glymphatic function is considered an important characteristic of cognitive decline, but the role of tau pathology as a mediator remains unclear. This study investigated whether tau burden mediates the association between diffusion tensor image analysis along the perivascular space (DTI-ALPS) and cognitive impairment or brain atrophy. Also, we explored whether DTI-ALPS index predicts longitudinal cognitive deterioration over time.MethodsWe included 144 individuals with mild cognitive impairment (MCI), Alzheimer's disease dementia (ADD), and other dementia, or normal cognition. All participants underwent 3.0-Tesla MRI, 18F-MK6240 and 18F-Flutemetamol PET scans, APOE genotyping, and comprehensive neuropsychological assessments. Among these, 101 were followed longitudinally for two years. Mediation analyses within a causal framework were used to investigate whether tau burden mediated the association between DTI-ALPS index and cognition function and structural MRI measures. Longitudinal associations were tested using linear mixed-effects models.ResultsDTI-ALPS index was significantly lower in cognitively impaired individuals compared to cognitively normal (CN) participants. Lower DTI-ALPS index was associated with higher tau burden and worse cognitive function. Tau burden was also inversely associated with cognition. Mediation analysis indicated that tau burden accounted for approximately 21-27% of the association between DTI-ALPS and cognition. Longitudinal analysis showed baseline lower DTI-ALPS index also predicted faster longitudinal cognitive decline.ConclusionOur findings suggest that the DTI-ALPS index is an indirect marker of glymphatic dysfunction associated with tau accumulation and cognitive decline. Tau pathology may partially link compromised glymphatic clearance to cognitive impairment.-
dc.languageEnglish-
dc.publisherSpringer-Verlag Berlin-
dc.relation.isPartOfEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING-
dc.relation.isPartOfEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING-
dc.titleTau PET imaging as a mediator between glymphatic dysfunction and cognitive decline: a cross-sectional and longitudinal study-
dc.typeArticle-
dc.contributor.googleauthorKo, Juyeon-
dc.contributor.googleauthorSon, Gayeong-
dc.contributor.googleauthorSeo, Ha Eun-
dc.contributor.googleauthorCho, Jaelim-
dc.contributor.googleauthorKim, Jae-Yoon-
dc.contributor.googleauthorLee, Sang-Yoon-
dc.contributor.googleauthorKim, Daegyeom-
dc.contributor.googleauthorPark, Shineui-
dc.contributor.googleauthorPark, Kee Hyung-
dc.contributor.googleauthorLockhart, Samuel N.-
dc.contributor.googleauthorKim, Dong-Hyun-
dc.contributor.googleauthorNoh, Young-
dc.identifier.doi10.1007/s00259-025-07756-4-
dc.relation.journalcodeJ00833-
dc.identifier.eissn1619-7089-
dc.identifier.pmid41578064-
dc.subject.keywordPET-
dc.subject.keywordGlymphatic dysfunction-
dc.subject.keywordCognitive function-
dc.subject.keywordBrain atrophy-
dc.subject.keywordTau deposition-
dc.contributor.affiliatedAuthorKo, Juyeon-
dc.contributor.affiliatedAuthorCho, Jaelim-
dc.identifier.scopusid2-s2.0-105028635675-
dc.identifier.wosid001667916000001-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2026-01-
dc.identifier.rimsid91836-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorPET-
dc.subject.keywordAuthorGlymphatic dysfunction-
dc.subject.keywordAuthorCognitive function-
dc.subject.keywordAuthorBrain atrophy-
dc.subject.keywordAuthorTau deposition-
dc.subject.keywordPlusPATHOLOGY-
dc.subject.keywordPlusCRITERIA-
dc.subject.keywordPlusPATHWAY-
dc.subject.keywordPlusDISEASE-
dc.subject.keywordPlusVERSION-
dc.subject.keywordPlusSYSTEM-
dc.subject.keywordPlusSCANS-
dc.subject.keywordPlusMILD-
dc.type.docTypeArticle; Early Access-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryRadiology, Nuclear Medicine & Medical Imaging-
dc.relation.journalResearchAreaRadiology, Nuclear Medicine & Medical Imaging-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.